Galderma Group AG
Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
- Conditions
- Interventions
- First Posted Date
- 2023-03-21
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 174
- Registration Number
- NCT05777759
- Locations
- 🇺🇸
United States, California, Manhattan Beach, California, United States
🇵🇷Galderma Research Site, San Juan, Puerto Rico
Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
- Conditions
- Interventions
- First Posted Date
- 2023-01-20
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 225
- Registration Number
- NCT05691972
- Locations
- 🇺🇸
Galderma Research Site, Nashville, Tennessee, United States
Healing Ointment Usage Post-surgical Procedure
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2023-01-17
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 15
- Registration Number
- NCT05686928
- Locations
- 🇺🇸
Legacy Dermatology, Frisco, Texas, United States
🇺🇸Derm Texas, Dallas, Texas, United States
Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition
- First Posted Date
- 2022-11-21
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 140
- Registration Number
- NCT05622812
- Locations
- 🇨🇦
Galderma Research Site, Westmount, Quebec, Canada
Comparative Ultrasound Analysis of Two Hyaluronic Acid Dermal Fillers
- Conditions
- Interventions
- First Posted Date
- 2022-11-21
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 11
- Registration Number
- NCT05622851
- Locations
- 🇺🇸
The Aesthetic Clinique, Santa Rosa Beach, Florida, United States
Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler
- First Posted Date
- 2022-11-17
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 21
- Registration Number
- NCT05620043
- Locations
- 🇺🇸
Miami Dermatology & Laser Institute, Miami, Florida, United States
An Open-label Study of Poly-l-lactic Acid for Correction of Wrinkles in the décolletage Area
- Conditions
- Interventions
- First Posted Date
- 2022-09-14
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 30
- Registration Number
- NCT05538728
- Locations
- 🇺🇸
Galderma Study Site, Solana Beach, California, United States
Sculptra Chart Review
- First Posted Date
- 2022-07-19
- Last Posted Date
- 2022-10-24
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 500
- Registration Number
- NCT05463978
- Locations
- 🇺🇸
Site Coordinator, New York, New York, United States
🇺🇸Galderma Research Site, New York, New York, United States
A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines
- Conditions
- Interventions
- First Posted Date
- 2022-07-19
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 605
- Registration Number
- NCT05463965
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
🇨🇳Tianjin University General Hospital, Tianjin, China
🇨🇳Peking University First Hospital, Beijing, China
Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe
- First Posted Date
- 2022-06-06
- Last Posted Date
- 2022-12-14
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 192
- Registration Number
- NCT05405985
- Locations
- 🇺🇸
Galderma Investigational Site 7024, Tempe, Arizona, United States
🇺🇸Galderma Investigational Site 7023, Lincoln, Nebraska, United States